Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announce...
Read moreResults show that higher doses of some anti-TB drugs are needed to reach sufficient concentrations at sites of infection
Read moreRespiratory allergy affects around 25% of the general population, especially in spring, at the height of the pollen season. We talk to Dr. Joan Bartra about the most common allergies and why they occu...
Read moreUn proyecto europeo liderado por el CSIC ha desarrollado una nueva tecnología basada en comunidades microbianas como alternativa sostenible para la producción de productos naturales
Read moreUn equipo de investigación de la URV-IIISPV y el Hospital Universitario Joan XXIII de Tarragona ha descubierto que este medicamento también ayuda a restaurar la grasa que rodea el área del intestin...
Read moreThis new collaboration comes from a call from AlmirallShare, the company's open innovation platform, to find innovative therapies for skin diseases
Read moreInitiatives seek to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge t...
Read moreEste marco puede utilizarse para generar fácilmente moléculas específicas capaces de "atacar" e inactivar un virus. La tecnología puede utilizarse para crear moléculas que se adapten fácilmente ...
Read moreLa vacuna Neoleish, con participación del Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), previene la infección y disminuye la presencia del parásito en más de un 90 %
Read moreThis article explores the current state of pharmaceutical innovation, predicts future trends, and discusses the role of artificial intelligence in shaping the industry. Furthermore, it highlights the ...
Read moreGood news for the scientific community! You can now purchase Bio-Techne products through Abyntek Biopharma.
Read moreThe use of biologics has grown exponentially in the last decade, driven by advances in genetic engineering, a deeper understanding of disease mechanisms, and an increasing demand for targeted thera...
Read more